28 results
SC 14D9/A
PRDS
Pardes Biosciences Inc
17 Aug 23
Tender offer solicitation (amended)
5:09pm
as Senior Vice President and Chief Scientific and Medical Officer of ViiV Healthcare from November 2009 until his retirement in October 2019. From September … . From 2005 until his retirement in July 2020, Dr. Varney served in roles of increasing responsibility and scope at Genentech, Inc., a biotechnology
SC 14D9
PRDS
Pardes Biosciences Inc
28 Jul 23
Tender offer solicitation
5:04pm
Healthcare from November 2009 until his retirement in October 2019. From September 2008 to November 2009, Dr. Pottage served as Senior Vice President, Head … board since August 2020 and a member of the Pardes Board since January 2021. From 2005 until his retirement in July 2020, Dr. Varney served in roles
SC TO-T
EX-99
FS Development Holdings II, LLC
28 Jul 23
Third party tender offer statement
5:01pm
foundations), retirement plans, controlled foreign corporations, passive foreign investment companies, persons who are subject to the alternative
8-K
EX-2.1
PRDS
Pardes Biosciences Inc
17 Jul 23
Entry into a Material Definitive Agreement
7:06am
mandated by applicable Law.
“Company Benefit Plan” means each bonus, pension, profit sharing, retirement, deferred compensation, incentive compensation … or employee of the Company, other than (i) any “multiemployer plan” (within the meaning of Section 3(37) of the Employee Retirement Income Security Act
8-K
EX-10.1
PRDS
Pardes Biosciences Inc
5 Jun 23
Departure of Directors or Certain Officers
4:02pm
of your normal or expected compensation for purposes of calculating any severance, retirement, welfare, insurance, or similar employee benefit.
4
8-K
EX-10.2
hy470s5 8lc
18 May 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.1
xn81dn p4h4
18 May 23
Departure of Directors or Certain Officers
4:10pm
DEF 14A
grn4 kreots59q90tt
26 Apr 22
Definitive proxy
6:07am
424B3
2ilx0jwrtpu 6ezv3jyi
1 Apr 22
Prospectus supplement
4:01pm
POS AM
hjrl90hn74ymnyk4z5x
30 Mar 22
Prospectus update (post-effective amendment)
7:32am
10-K
EX-10.21
t2tpod
29 Mar 22
Annual report
5:29pm
10-K
EX-10.22
qpnoyzkx54r
29 Mar 22
Annual report
5:29pm
10-K
awf69ywi
29 Mar 22
Annual report
5:29pm
424B3
lcez7
1 Feb 22
Prospectus supplement
5:03pm
8-K
EX-2.1
5fnon2q1 1l
29 Jun 21
Entry into a Material Definitive Agreement
6:09am
8-K
EX-10.3
zsj74fn slyr
29 Jun 21
Entry into a Material Definitive Agreement
6:09am
425
EX-2.1
qkllonyk tftjfyfa
29 Jun 21
Business combination disclosure
6:07am